Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
about
Medical management of congestive heart failure.Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure.The addition of prazosin to standard triple therapy in the treatment of severe hypertension.Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment.Acute and chronic haemodynamic effects of prazosin in left ventricular failure.Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Reassessing the use of vasodilators in heart failure.Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.Left ventricular dysfunction and heart failure. Mechanistic and therapeutic distinctions.Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.Treatment of congestive heart failure. Pathophysiologic and pharmacologic concepts.Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function.Long-term treatment of congestive heart failure with captopril.Acute and chronic effects of captopril therapy in patients with refractory heart failure.Orthostatic hypotension after the first administration of prazosin in hypertensive patients: role of the plasma volume.Mortality in congestive heart failure: effects of vasodilator therapy.Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure.Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.Influence of repeated prazosin administration on cardiovascular responses in rats and rabbits.Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.Prazosin in the treatment of severe chronic congestive cardiac failure.
P2860
Q33558612-E394719E-87D8-4CDD-B351-AE65FA78AF05Q34417529-F5522F75-477A-48FA-B0C6-F23FEC599F31Q34449958-E0436538-F30D-4DF3-A386-EF82A99184D2Q34778812-6CB3F701-9E55-4D00-B9E2-68A57F7FC428Q36745911-5FF7B9E8-44D8-44DF-8BE1-E66D0612B7C5Q36752161-A557E624-E231-4B31-9F4C-28E53D9A9325Q36758499-6CA3D9D7-1E8A-4D81-AF8F-49BBD12200ACQ36778977-CC450938-D854-42CE-B3A4-A3D640735869Q36854757-C4ACE0F1-151A-4114-B40F-10197B599471Q38055507-09347752-AEA4-4ED3-95AD-7D117B27DB5AQ38215916-5A9C56AA-6177-4B34-8AB8-FA776590DA61Q41066083-1C448A57-3167-4D72-A80D-49C0C5769FD5Q41320587-D064BD67-E693-47B1-9489-7793ADA41BF7Q41323051-E6027D37-7D33-44B6-AF6E-9214C67A7F48Q41324876-CE1F3B2D-8042-484C-81F9-45F5C39416C7Q41439595-8389BD4A-68D5-45BE-8D75-92094720FE8BQ41820329-A7864DDB-9456-445C-A5D6-2ACC604F2D50Q41829898-8046757E-13AB-429B-916C-8B1F2C58A23DQ42119132-91074332-2BDA-4F31-B663-AB8F8DDD4271Q42242883-516A69DC-A59D-4722-8965-785315E0FD82Q42561050-530227CF-B51F-4A63-9317-37070A17A50BQ54277743-EBD6C9C2-C210-47CC-8726-4CFC7CF5CB91Q54323640-44F77A4A-E0BA-4A1C-84D0-2DE336159A60Q54414228-54F87591-64CD-4843-94E7-9842CE9B386BQ54435436-E920C3EF-DD80-426B-8CED-98CB29BB9544Q54481299-0F5B0899-06A8-4D75-950C-D066629BF682Q54491368-E54F0504-1878-48A1-9A95-F05787CAC081Q54511734-6351DCAC-6213-422C-9022-0EA052742F62Q54549770-09F89C46-6A08-4241-AB56-90FF49B2F40B
P2860
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
description
1979 nî lūn-bûn
@nan
1979 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի մարտին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@ast
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@en
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@nl
type
label
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@ast
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@en
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@nl
prefLabel
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@ast
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@en
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@nl
P2093
P356
P1433
P1476
Hemodynamic and clinical tachy ...... onic congestive heart failure.
@en
P2093
P304
P356
10.1161/01.CIR.59.3.531
P407
P577
1979-03-01T00:00:00Z